Hysterectomy

Minimally Invasive Hysterectomy Linked to Favorable Survival in Uterine Cancer

Minimally Invasive Hysterectomy Linked to Favorable Survival in Uterine Cancer

Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.

Risk and Benefits of Hysterectomy With Electric Power Morcellation Vary With Age

By

The use of electric power morcellators have varying risks and benefits that vary with patient age, according to a recent study.

Low estrogen therapy utilization after hysterectomy deadly

Low estrogen therapy utilization after hysterectomy deadly

Thousands of deaths estimated in 50- to 59-year-old hysterectomized women, because of avoiding estrogen therapy.

Higher risk of uterine cancer recurrence when radiation therapy after hysterectomy is delayed

The risk of uterine cancer recurrence may be increased by waiting too long after a hysterectomy to begin radiation therapy. For patients with uterine cancer who are not receiving chemotherapy, tumors were found to be more likely to return if radiation therapy was delayed 9 weeks or longer following surgery.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs